Start with your question. Search first, choose the closest subject and keep personal details private. Posting guidelines
Notifications
Clear all
Topic starter
06/07/2020 7:27 am
Trying to separate three different claims about retatrutide: that it is the right molecule, that it is the right dose, and that it does something useful.
The comparison group matters more than the compound when the outcome is something as fuzzy as focus.
Forum consensus and published consensus diverged here about five years ago and never reconverged.
My rule now: if a claim cannot survive being written down with the numbers attached, it is marketing.
Sulphur burps and nausea for the first weeks are the usual complaint and they do fade.
What would change your mind about this?